New treatment strategy exploits acquired vulnerability in drug-resistant melanoma
Cancer cells that develop resistance to drugs pay a price for this by simultaneously developing a new vulnerability. If this acquired vulnerability can be identified, it may be exploited clinically. A team of cancer researchers, ...
May 10, 2018
2
17